Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Plos Neglected Tropical Diseases
|
September 14, 2017
Melioidosis in lower provincial Cambodia: A case series from a prospective study of sepsis in Takeo Province
Kevin L Schully, Catherine M Berjohn, Angela M Prouty, et al.
Plos One
|
October 11, 2019
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015
Naiki Attram, Bright Agbodzi, Helena Dela, et al.
Plos One
|
February 13, 2025
Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes
Harini Ganeshan, Jun Huang, Maria Belmonte, et al.
Plos One
|
December 2, 2020
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial
Kawsar R Talaat, Chad K Porter, Kayla M Jaep, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Open Forum Infectious Diseases
|
January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
BMC Infectious Diseases
|
June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Emerging Infectious Diseases
|
February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers
Eric D Laing, Carol D Weiss, Emily C Samuels, et al.
Open Forum Infectious Diseases
|
February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers
Emilie Goguet, John H Powers, Cara H Olsen, et al.
Plos One
|
September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Plos Neglected Tropical Diseases
|
September 14, 2017
Melioidosis in lower provincial Cambodia: A case series from a prospective study of sepsis in Takeo Province
Kevin L Schully, Catherine M Berjohn, Angela M Prouty, et al.
Plos One
|
October 11, 2019
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015
Naiki Attram, Bright Agbodzi, Helena Dela, et al.
Plos One
|
February 13, 2025
Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes
Harini Ganeshan, Jun Huang, Maria Belmonte, et al.
Plos One
|
December 2, 2020
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial
Kawsar R Talaat, Chad K Porter, Kayla M Jaep, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Open Forum Infectious Diseases
|
January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
BMC Infectious Diseases
|
June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Emerging Infectious Diseases
|
February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers
Eric D Laing, Carol D Weiss, Emily C Samuels, et al.
Open Forum Infectious Diseases
|
February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers
Emilie Goguet, John H Powers, Cara H Olsen, et al.
Plos One
|
September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.
Page
of 2